 Home > Medical News > Medical Research Articles > Baxter anti-avian influenza vaccine will enter Phase III clinical study

Baxter anti-avian influenza vaccine will enter Phase III clinical study

 Last Update: 2020-07-08
 Source: Internet
 Author: User

Tags

9 15 simplified

anti jo 1

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 29,, Baxter announced that its anti-avian influenza virus H
5N
1vaccine is ready to enter Phase III clinicalBaxter's shares rose to $53.15 at 9:50 a.mEstIt is reported that Baxter's anti-avian influenza virus H
5N
1vaccine can produce an immune response at a low dose, Phase III clinical research will be completed by the end of this year(Wei Wei)(reproduced from the Medical Economics Daily)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Neopentyl Glycol CAS NO.126-30-7 99% High Quality Factory Supply

CAS No.: 126-30-7

Industrial Grade

$1.7-2/KG FOB

Factory Supply Tirzepatide 10 mg 15mg Weight Loss Peptide 10mg 99.9% CAS: 2023788-19-2

CAS No.: 2023788-19-2

Pharmacy Grade

$4-5/UNIT FOB

good quality 2cb wholesale

CAS No.: 58743-75-2

$2-2.2/MT EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.